Focused Clinical Oversight for CNS and Psychiatry Research
UK Hospitals
Hospital Staff Relationships
Years of Experience
While we maintain a selective and focused portfolio, we have developed a distinct capability in managing the intricate hurdles of Central Nervous System (CNS) and Psychiatric research. Operating as a global CRO based in the UK, we provide either targeted phase-support or comprehensive, full-service management for neuroscience and mental health trials.
We partner with biotech firms, pharmaceutical companies, and academic institutions to deliver studies that are scientifically exacting and operationally resilient, particularly when managing the subjective endpoints and high placebo responses characteristic of these fields.
Navigating the Nuances of Neuropsychiatric Studies
Trials in CNS and Psychiatry require more than standard oversight; they demand a team that understands the variability of cognitive, motor, and behavioural assessments.
Whether the study involves neurodegenerative conditions or complex psychiatric disorders, the protocol must be meticulously designed to ensure inter-rater reliability.
We design frameworks that focus on rigorous investigator training and the use of standardised digital and clinical assessment tools to ensure that data captured across global sites is consistent and reproducible.
Expert Site Selection and Clinical Intelligence
Finding the right environment for a CNS or Psychiatry trial requires a deep understanding of site-level facilities and local patient access.
Through our experience with UK and European sites, we identify the specialist neurology clinics, memory services, and psychiatric research units that have the dedicated space and certified raters needed for complex evaluations.
Our advantage comes from years of direct collaboration. We know which sites have the administrative agility to set up studies quickly and which units have the strongest recruitment track records for specific, often hard-to-reach patient populations.
By working with us, you gain access to this local intelligence, ensuring your trial is placed at sites that are technically equipped and operationally ready, avoiding the delays often associated with more saturated units.
Coordinating Complex Diagnostics
The success of modern neuroscience trials is predicated on the rigorous standardisation and rater qualification of site staff to ensure the uniform delivery of complex questionnaires and subjective assessments.
We specialise in mitigating high placebo responses through intensive rater training and inter-rater reliability programmes, establishing a singular, uniform approach to how scales are administered across all locations.
Frequently Asked Questions
What range of services do you provide for CNS and Psychiatry trials?
We offer a full-service model including protocol design, regulatory submissions, site management, and clinical monitoring. Our support covers specific indications including neurodegenerative disorders, chronic pain, and mood disorders.
How do you help sponsors select the right European sites?
Because we know the UK and European sites so intimately, we guide sponsors toward locations that have the specific infrastructure required, such as advanced neuro-imaging suites or dedicated psychiatric research beds.
Can you handle the regulatory hurdles for novel neurological therapies?
Yes. Our team is well-versed in the specific regulatory requirements for CNS-acting drugs, including the management of controlled substances. We manage complex submissions to the MHRA and EMA, ensuring all safety reporting meets international standards.
How do you ensure consistency across different raters and sites?
We implement rigorous rater-training and certification programmes at the outset. By working closely with site investigators and using standardised electronic assessments, we ensure that subjective data points are captured consistently, regardless of the geographical location of the clinic.
What makes your project teams different from a large, generic CRO?
Continuity and technical focus. In CNS and Psychiatry research, where understanding the nuances of cognitive data is critical, having the same senior experts from planning through to close-out prevents data errors and delays.
Do you support companies with early-phase and "First-in-Human" trials?
Absolutely. We have extensive experience with early-phase trials studies for novel neuropsychiatric therapies both in patients and healthy volunteers. We provide the agile framework needed to gather early safety and efficacy data before moving into larger pivotal trials.
Case Study: Rapid Site Mobilisation for an Academic-Led Bipolar Disorder Study
We acted as the partner for a complex clinical investigation evaluating the impact of an atypical antipsychotic on cognitive functioning in patients with bipolar disorder.
As this was led by an academic sponsor, the study required a partner capable of balancing rigorous clinical standards with the specific governance and budgetary frameworks of university-led research.
The programme involved the precise coordination of high-frequency cognitive batteries across multiple specialist psychiatric units.
By leveraging our deep knowledge of UK psychiatric research networks, we ensured the study remained compliant with GCP while meeting the unique reporting requirements of the academic sponsor.
Our senior-led oversight ensured that the cognitive data was captured with the precision necessary to support the study’s primary efficacy analysis.